Purasomes + PRP with AMPLEX+ – natural vesicular signalling and documented growth factors
Within regenerative and aesthetic medicine we have moved from "delivery of content" to biological communication. Where PRP creates an active signalling environment through growth factors, Purasomes represents a new generation of natural signalling vesicles, a clear distinction from synthetic nanocarriers that primarily function as passive transport.
It is therefore increasingly important to distinguish between natural vesicular signalling (which the body recognises) and synthetic delivery systems without biological intelligence.
What is Purasomes?
Purasomes can be described as natural vesicular signaling, genuine biological communication, not a synthetic imitation. They consist of natural signalling vesicles that can help coordinate reparative processes in tissue.
Key features of Purasomes:
-
Hundreds of natural proteins, miRNAs and lipids
-
Receptor-mediated uptake (targeted interaction with cells)
-
Transcriptional modulation (can influence how cells respond)
-
Fully natural and biodegradable
-
In-vitro and translational data linked to wound healing
-
True regenerative communication, not a synthetic imitation
The core principle is simple: Purasomes communicates like biology.
Synthetic Nanocarriers – delivery without communication
Synthetic nanocarriers represent a different principle:
-
Passive delivery, no biological signalling
-
Often a single synthetic payload
-
Diffusion-based delivery
-
Dependent on polymer type and material properties
-
Delivery without intelligence
Where Purasomes activates and communicates, nanocarriers primarily deliver a substance, without a biological "language".
PRP as a biological platform – and why AMPLEX+ matters
PRP (Platelet-Rich Plasma) is an established method for creating a regenerative environment through the release of growth factors and cytokines from platelets. The effect of PRP, however, depends on quality, concentration and protocol.
When PRP is enhanced with AMPLEX+, measured values show a more bioactive signalling environment compared to plain plasma.
Growth factors: PRP with AMPLEX+ vs. plain plasma (pg/ml)
Measured concentrations show significant differences:
PDGF (Platelet derived growth factor):
PRP with AMPLEX+: 6770
Plain plasma: 114
TNF alpha (Tumor necrosis factor):
PRP with AMPLEX+: 263
Plain plasma: 11.91
VEGF (Vascular endothelial growth factor):
PRP with AMPLEX+: 2187
Plain plasma: 46
HGF (Hepatocyte growth factor):
PRP with AMPLEX+: 3057
Plain plasma: 61.7
FGF-2 (Fibroblast growth factor):
PRP with AMPLEX+: 9305
Plain plasma: 136
TGF-β1 (Transforming growth factor):
PRP with AMPLEX+: 4317
Plain plasma: 1810
IGF-1 (Insulin-like growth factor):
PRP with AMPLEX+: 1337
Plain plasma: 105.8
G-CSF:
PRP with AMPLEX+: 836
Plain plasma: Not detectable
GM-CSF:
PRP with AMPLEX+: 9407
Plain plasma: Not detectable
SDF-1 (Stromal derived factor-1):
PRP with AMPLEX+: 6329
Plain plasma: 1760
NGF (Nerve growth factor):
PRP with AMPLEX+: 431
Plain plasma: 79
What does this mean in practice?
These factors are associated with:
-
Cell proliferation and tissue repair (PDGF, IGF-1)
-
Angiogenesis and microcirculation (VEGF)
-
Collagen production and skin renewal (FGF-2)
-
Remodelling and inflammation regulation (TGF-β1)
-
Recruitment of reparative cells (SDF-1)
-
Immune modulation and mobilisation (G-CSF and GM-CSF)
PRP with AMPLEX+ therefore presents a significantly more bioactive environment than plain plasma.
When Purasomes and PRP are combined
PRP provides the body with a growth-factor signal.
Purasomes represents vesicular, receptor-mediated communication.
When these principles are combined, you get both:
-
A rich signalling environment of growth factors
-
Natural vesicular communication with broad biological content
-
Potentially a more coordinated and precise tissue response
This represents a clear distinction from synthetic nanocarriers, which primarily offer transport without biological intelligence.
Conclusion
The future of regenerative aesthetics and skin health is not only about delivering active substances, but about activating the body's own biological systems.
Purasomes represents true vesicular signalling with natural biological breadth.
Synthetic nanocarriers deliver, but do not communicate.
PRP with AMPLEX+ shows significantly higher levels of key growth factors than plain plasma.
When biological signalling and concentrated growth factors are combined correctly, this opens the door to more precise, effective and biologically natural treatment protocols.